Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

Retrospective Survey of Bone Fracture in Post-Menopausal Breast Cancer Patients With Arimidex 1 mg as Adjuvant Therapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00859560

Enrollment

2205

Registered

2009-03-11

Start date

2008-01-31

Completion date

2008-12-31

Last updated

2009-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, post-menopausal women, Arimidex, bone fracture

Brief summary

The retrospective survey is to investigate the incidence of bone fracture in post-menopausal breast cancer patients with Arimidex 1mg, who were previously registered for the clinical experience investigation.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Post-menopausal breast cancer patients treated with Arimidex 1mg at the time of previously conducted clinical experience investigation.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Bone fracture incidence	Time since starting Arimidex

Secondary

Measure	Time frame
Survival	Time since starting Arimidex
Bone density measurement	Time since starting Arimidex

Outcome results